Carlsmed, Inc. Operating Cash Flow
Carlsmed, Inc. (CARL) reported Operating Cash Flow of -$20.36 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- Carlsmed, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$7.36M.
- Carlsmed, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$13.01M.
- Carlsmed, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$5.32M.
- Carlsmed, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$8.46M.
- Carlsmed, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$28.98M.
- Carlsmed, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$25.47M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$7.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$20.36M 10-Q · filed 2026-08-05 | -$25.69M derived: sum of 3 quarters · filed 2026-08-05 | -$34.15M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$13.01M 10-Q · filed 2026-05-05 | -$18.33M derived: sum of 2 quarters · filed 2026-05-05 | -$26.79M derived: sum of 3 quarters · filed 2026-05-05 | -$33.83M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$5.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$13.78M derived: sum of 2 quarters · filed 2026-02-25 | -$20.82M derived: sum of 3 quarters · filed 2026-08-05 | -$28.98M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$8.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$15.50M derived: sum of 2 quarters · filed 2026-08-05 | -$23.66M 10-Q · filed 2025-11-06 | -$27.86M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$7.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$15.20M 10-Q · filed 2026-08-05 | -$19.40M derived: sum of 3 quarters · filed 2026-08-05 | -$26.98M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$8.15M 10-Q · filed 2026-05-05 | -$12.36M derived: sum of 2 quarters · filed 2026-05-05 | -$19.94M derived: sum of 3 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$11.78M derived: sum of 2 quarters · filed 2026-02-25 | -$25.47M 10-K · filed 2026-02-25 | |
| 2024-09-30 | -$7.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$21.26M 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$13.68M 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |